Mayne Pharma Quote - MYX

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

5.29

( 0.76% )

Bid

5.25

Offer

5.35

Volume

181,182

5.21 Day's Range 5.35

3.74 52 Week Range 7.31

Market Cap

450.043M

Previous Close

5.25

Open

5.21

Last Trade

5.34

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

802,225

Shares Outstanding

85,074,288

Dividend Yield

PE Ratio

-2.58

Earnings Per Share (EPS)

-2.05

Revenue

386.19M

Net Profit

-174.23M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.maynepharma.com

Headquarters

Adelaide, South Australia, Aus

Founded

Mayne Pharma Group Ltd is listed in the Pharmaceutical Preparations sector of the Australian Stock Exchange with ticker MYX. The last closing price for Mayne Pharma was AUD5.25. Over the last year, Mayne Pharma shares have traded in a share price range of AUD 3.74 to AUD 7.31.

Mayne Pharma currently has 85,074,288 shares in issue. The market capitalisation of Mayne Pharma is AUD446.64 million. Mayne Pharma has a price to earnings ratio (PE ratio) of -2.58.

Mayne Pharma Launches Foam Dermatology Products in US

By Rebecca Thurlow SYDNEY--Mayne Pharma Group Ltd. (MYX.AU) said Wednesday it has launched its foam dermatology products Fabior and Sorilux in the...

Mayne Pharma to buy 42 drugs

/newsletter/barneyc/476/mayne-pharma-to-buy-42-drugs

Mayne Pharma Acquires Rights to a Portfolio of Dermatology Foam Products Including Fabior® and Sorilux®

Mayne Pharma Group Limited (“Mayne Pharma”) (ASX: MYX) has acquired a portfolio of dermatology foam products and related assets (“Foam...

Mayne Pharma Buys US Drugs from Teva, Allergan for $652 Million

By Rebecca Thurlow SYDNEY--Mayne Pharma Group Ltd. (MYX.AU) acquired a portfolio of U.S. generic drugs from Teva Pharmaceutical Industries Ltd...

Asian Shares Mostly Higher

Australian shares are nearing their highest level since late October on Monday, though falling commodities prices muted gains triggered by...

3 stocks in the buy zone and 1 to avoid

http://www.fool.com.au/2015/05/07/3-stocks-in-the-buy-zone-and-1-to-avoid/

Actavis Earnings Soar as Closing of Allergan Deal Looms

By Michael Calia Actavis PLC raised its profit guidance for 2015, while acquisitions again helped drive revenue growth in the fourth quarter, as...

Actavis to Divest U.S. Doryx Rights Before Allergan Deal

Actavis PLC (ACT) will sell the U.S. rights to an acne treatment as it seeks to refine its dermatology portfolio ahead of its purchase of Botox...

Actavis to Divest Itself of U.S. Doryx Rights Ahead of Allergan Deal -- Update

By Maria Armental and Robb M. Stewart Actavis PLC (ACT) will sell the U.S. rights to a acne treatment as it seeks to refine its dermatology...

HedgePath Pharmaceuticals Welcomes Three New Board Members

HedgePath Pharmaceuticals Welcomes Three New Board Members Stefan Cross, Dr. Dana Ono and Mark Watson add significant biotechnology, capital...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.26	5.1689860835	5.03	5.35	4.99	204725	5.15177051	DE
4	0.16	3.11890838207	5.13	5.35	4.86	282301	5.1059039	DE
12	-1.68	-24.1032998565	6.97	7.16	4.14	802225	5.50908998	DE
26	0.67	14.5021645022	4.62	7.31	4.14	697722	6.19151748	DE
52	1.07	25.355450237	4.22	7.31	3.74	428342	5.89000898	DE
156	-0.51	-8.79310344828	5.8	8.5	2.68	1106475	5.55958533	DE
260	-3.31	-38.488372093	8.6	11.8	2.68	1930840	6.13040791	DE

MYX - Frequently Asked Questions (FAQ)

What is the current Mayne Pharma share price?

The current share price of Mayne Pharma is AUD 5.29

How many Mayne Pharma shares are in issue?

Mayne Pharma has 85,074,288 shares in issue

What is the market cap of Mayne Pharma?

The market capitalisation of Mayne Pharma is AUD 446.64M

What is the 1 year trading range for Mayne Pharma share price?

Mayne Pharma has traded in the range of AUD 3.74 to AUD 7.31 during the past year

What is the PE ratio of Mayne Pharma?

The price to earnings ratio of Mayne Pharma is -2.58

What is the cash to sales ratio of Mayne Pharma?

The cash to sales ratio of Mayne Pharma is 1.17

What is the reporting currency for Mayne Pharma?

Mayne Pharma reports financial results in AUD

What is the latest annual turnover for Mayne Pharma?

The latest annual turnover of Mayne Pharma is AUD 386.19M

What is the latest annual profit for Mayne Pharma?

The latest annual profit of Mayne Pharma is AUD -174.23M

What is the registered address of Mayne Pharma?

The registered address for Mayne Pharma is 1538 MAIN NORTH ROAD, SALISBURY SOUTH, ADELAIDE, SOUTH AUSTRALIA, 5106

What is the Mayne Pharma website address?

The website address for Mayne Pharma is www.maynepharma.com

Which industry sector does Mayne Pharma operate in?

Mayne Pharma operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
IMUImugene Limited	AUD 0.425 (2,935.71%)	262.98k
IMUOEImugene Ltd	AUD 0.005 (400.00%)	3.86M
SUMOSummit Minerals Ltd	AUD 0.004 (100.00%)	707.51k
BPHOCommon Stock	AUD 0.002 (100.00%)	4.36M
TD1Tali Digital Limited	AUD 0.002 (100.00%)	10.54M
ICUInvestor Centre Ltd	AUD 0.001 (-66.67%)	752.31k
MGUOMagnum Mining and Exploration Ltd	AUD 0.001 (-50.00%)	1M
M2ROAMiramar Resources Limited	AUD 0.001 (-50.00%)	3.5M
ADXOADX Energy Limited	AUD 0.001 (-50.00%)	440k
HLXHelix Resources Limited	AUD 0.001 (-50.00%)	4.01M
ATHAlterity Therapeutics Ltd	AUD 0.015 (66.67%)	92.96M
DTRDateline resources Ltd	AUD 0.0915 (2.23%)	66.57M
SYASayona Mining Limited	AUD 0.0185 (8.82%)	57.17M
PLSPilbara Minerals Limited	AUD 1.555 (1.63%)	53.23M
LKYLocksley Resources Ltd	AUD 0.085 (23.19%)	49.61M